Table 1.
Demographic and clinical data by treatment group
| Nonsteroid treatment | Steroid treatment | p value (<0.05) | |
|---|---|---|---|
| Subjects, n (%) | 126 (48) | 137 (52) | |
| Males, n (%) | 106 (84.1) | 126 (92) | 0.057 |
| Mean age ± SD, years | 19.99±2.40 | 20.30±2.38 | 0.314 |
| Time schedule, days | |||
| Time from injury to first audiometry | 5.4±5.25 | 4.79±7.86 | 0.467 |
| Time from first audiometry to physician | 7.75±7.4 | 3.86±3.75 | <0.0001 |
| Presenting symptoms, n (%) | |||
| Hearing loss | 75 (59.5) | 99 (72.3) | 0.037 |
| Tinnitus | 96 (76.2) | 101 (73.7) | 0.671 |
| Hyperacusis | 35 (27.8) | 53 (38.7) | 0.068 |
| Aural fullness | 35 (27.8) | 46 (33.6) | 0.35 |
| Otalgia | 49 (38.9) | 56 (40.9) | 0.801 |
| Dizziness | 15 (11.9) | 19 (13.9) | 0.714 |
| Others | 3 (2.3) | 11 (8.0) | 0.041 |
| Noise exposure setting, n (%) | |||
| Open | 90 (71.4) | 100 (73) | 0.465 |
| Closed | 32 (25.4) | 29 (21.2) | − |
| Mixed | 1 (0.8) | 0 (0) | − |